Surg Clin. 2019; 99: 357-367
- Zheng-Pywell R.
- Reddy S.
- Ampullary Cancer
Demographics, tumor characteristics, treatment, and clinical outcomes of patients with ampullary cancer: a Surveillance, Epidemiology, and End Results (SEER) cohort study.Minerva Gastroenterol Dietol. 2019; 65: 85-90
- Albores-Saavedra J.
- et al.
Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program.J Surg Oncol. 2009; 100: 598-605
Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.J Surg Oncol. 2012; 105: 266-272
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.Ann Surg Oncol. 2009; 16: 836-847
Nationwide improvement of only short-term survival after resection for pancreatic cancer in The Netherlands.Pancreas. 2012; 41: 1063-1066
FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer.N Engl J Med. 2018; 379: 2395-2406
Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.Jpn J Cancer Res. 1994; 85: 161-166
- Albores-Saavedra J.
- et al.
The WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts.A commentary on the second edition. Cancer. 1992; 70: 410-414
Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.Arch Pathol Lab Med. 2009; 133: 67-71
Management of cancer of the ampulla of Vater: does local resection play a role?.Dig Surg. 2003; 20: 511-515
Pancreaticoduodenectomy is curative in the majority of patients with node-negative ampullary cancer.Arch Surg. 2005; 140 (): 529-532
Long-term survival and recurrence patterns in ampullary cancer.Pancreas. 2006; 32: 390-395
Improved survival for adenocarcinoma of the ampulla of Vater: fifty-five consecutive resections.Arch Surg. 2003; 138 (): 941-948
Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer.Ann Surg Oncol. 2007; 14: 50-60
Ampulla of vater cancers: T-stage and histological subtype but not Dpc4 expression predict prognosis.Virchows Arch. 2002; 441: 19-24
Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.Am J Surg Pathol. 2004; 28: 875-882
Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.Virchows Arch. 2007; 451: 649-657
Tumors of the ampulla of vater: histopathologic classification and predictors of survival.J Am Coll Surg. 2008; 207: 210-218
Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma.BMC Cancer. 2008; 8: 170
Important prognostic factors in adenocarcinoma of the ampulla of Vater.Am Surg. 2009; 75 (): 754-760
Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.Am J Surg Pathol. 2009; 33: 691-704
Differential features of pancreatobiliary- and intestinal-type ampullary carcinomas at MR imaging.Radiology. 2010; 257: 384-393
- de Paiva Haddad L.B.
- et al.
Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.J Gastrointest Surg. 2010; 14: 719-728
Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.Am J Clin Pathol. 2011; 135: 202-211
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.J Clin Oncol. 2013; 31: 1348-1356
Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.Pancreas. 2013; 42: 60-66
Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.PLoS One. 2013; 8e65144
Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?.Ann Surg Oncol. 2013; 20: 430-439
Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.J Surg Oncol. 2014; 110: 156-162
Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.Pancreas. 2014; 43: 692-697
Treatment utilization and surgical outcome of ampullary and duodenal adenocarcinoma.J Surg Oncol. 2014; 109: 556-560
Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater.Surgery. 2015; 158: 151-161
Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.Br J Cancer. 2015; 113: 64-68
Survival in ampullary cancer: potential role of different KRAS mutations.Surgery. 2015; 157: 260-268
Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.BMC Gastroenterol. 2015; 15: 165
Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.J Surg Oncol. 2016; 114: 119-127
Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.Hum Pathol. 2016; 50: 90-100
Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.J Clin Pathol. 2016; 69: 431-439
Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.Mod Pathol. 2016; 29: 1575-1585
Differential expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in intestinal and pancreatobiliary-type Ampullary carcinomas.Int J Surg Pathol. 2017; 25: 31-40
Association of histopathologic phenotype of periampullary adenocarcinomas with survival.JAMA Surg. 2017; 152: 82-88
Ampulla of vater carcinoma: sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations.Ann Surg. 2018; 267: 149-156
Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma.J Surg Oncol. 2019;
Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy.Pancreatology. 2019; 19: 316-324
The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma.Sci Rep. 2019; 912676
Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: international multicenter cohort study.Ann Surg. 2020; 272: 1086-1093
Long-term outcomes after pancreatoduodenectomy for ampullary cancer: the influence of the histological subtypes and comparison with the other periampullary neoplasms.Pancreatology. 2021; 21: 950-956
Clinicopathological prognostic factors and Chemotherapeutic outcome for two histopathological types of ampulla of vater adenocarcinoma.Front Oncol. 2021; 11616108
MOOSE reporting guidelines for meta-analyses of observational studies.JAMA Surg. 2021; 156: 787-788
Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.Stat Med. 1998; 17: 2815-2834
Practical methods for incorporating summary time-to-event data into meta-analysis.Trials. 2007; 8: 16
IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.BMC Med Res Methodol. 2021; 21: 111
Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study.Br J Surg. 2020; 107: 1171-1182
Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - a multicenter cohort study.Pancreatology. 2020; 20: 433-441
Characterization of various cell lines from different ampullary cancer subtypes and cancer associated fibroblast-mediated responses.BMC Cancer. 2016; 16: 195
Ampulla of Vater and Common Bile Duct,
October 2019 ()
- Campbell F.
- Cairns A.
- Duthie F.
- Feakins R.
The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater.Am J Surg Pathol. 2014; 38: 1371-1379
Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.Hum Pathol. 2013; 44: 2213-2219
Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.Am J Surg Pathol. 2005; 29: 359-367
Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.J Surg Oncol. 2019; 119: 295-302